Literature DB >> 15787742

Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.

J W Wells1, D Darling, F Farzaneh, J Galea-Lauri.   

Abstract

Murine bone marrow-derived dendritic cells (DC) can be generated by culture in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) alone or GM-CSF in conjunction with interleukin-4 (IL-4). However, these two culture methods result in the production of heterogeneous DC populations with distinct phenotypic and stimulatory properties. In this study, we investigated the properties of DC generated under serum-free conditions in the presence or absence of IL-4 and compared their yield and phenotype to that of DC generated in the presence of fetal calf serum (FCS) (+/-IL-4). We did not observe a significant difference in the total cell yield between these four culture conditions, although the proportion of CD11c+ DC in cultures that received FCS was higher than that of their counterparts generated under serum-free conditions. Also, the four culture conditions generated CD11c+ DC with comparable levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 expression, with the exception of cells cultured under serum-free conditions in the absence of IL-4, which displayed suboptimal levels of these markers. Moreover, we compared the functional and stimulatory properties of DC generated under serum-free conditions in the presence or absence of IL-4. DC cultured in the presence of IL-4 were stronger stimulators of allogeneic splenocytes in a primary mixed lymphocyte reaction (MLR) and of naive antigen-specific OT-II transgenic T cells when pulsed with the class II ovalbumin (OVA)323-339 peptide or whole OVA protein than DC cultured in the absence of IL-4. However, both DC populations displayed a similar capacity to take up fluorescein isothiocyanate (FITC)-albumin by macropinocytosis and FITC-Dextran by the mannose receptor and to secrete IL-12 in response to stimulation with lipopolysaccharide (LPS) or an agonistic anti-CD40 monoclonal antibody. Therefore, we conclude that although both DC culture methods result in the production of DC with similar functional abilities, under serum-free conditions, DC cultured in GM-CSF and IL-4 show an increased stimulatory potential over DC cultured in GM-CSF alone. This is an important consideration in the design of experiments where DC are being exploited as immunotherapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787742     DOI: 10.1111/j.1365-3083.2005.01556.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  19 in total

1.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

Review 2.  Generation and maturation of bone marrow-derived DCs under serum-free conditions.

Authors:  Sung Jung Kim; Betty Diamond
Journal:  J Immunol Methods       Date:  2007-04-09       Impact factor: 2.303

3.  Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.

Authors:  Paul Hatfield; Alison E Merrick; Emma West; Dearbhaile O'Donnell; Peter Selby; Richard Vile; Alan A Melcher
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

4.  Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Authors:  Yifang Chen; Sahil Khanna; Carl S Goodyear; Yong Beom Park; Eyal Raz; Steffen Thiel; Caroline Grönwall; Jaya Vas; David L Boyle; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

5.  The dynamic changes of CD3e-CD11c+ dendritic cells in spleens and bone marrow of mice infected with Schistosoma japonicum.

Authors:  Lin Chen; Qingzhou Chen; Wei Hou; Li He
Journal:  Parasitol Res       Date:  2017-02-10       Impact factor: 2.289

6.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

7.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

8.  Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.

Authors:  Christopher J Farrell; Cecile Zaupa; Zachary Barnard; Jason Maley; Robert L Martuza; Samuel D Rabkin; William T Curry
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

9.  Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma.

Authors:  Ji-Won Jung; Margaret Veitch; Jennifer A Bridge; Nana H Overgaard; Jazmina L Cruz; Richard Linedale; Michael E Franklin; Nicholas A Saunders; Fiona Simpson; Ian H Frazer; Raymond J Steptoe; James W Wells
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

10.  Neuropeptides control the dynamic behavior of airway mucosal dendritic cells.

Authors:  Sabrina Voedisch; Sabine Rochlitzer; Tibor Z Veres; Emma Spies; Armin Braun
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.